StonvexLoading…
StonvexStonvexStonvexCore line items from CNXN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $721.87M | $2.87B | $2.17B | $1.46B |
Operating Income | $20.23M | $99.28M | $75.69M | $45.42M |
Net Income | $17.22M | $83.72M | $63.01M | $38.27M |
EPS (Diluted) | $0.68 | $3.27 | $2.45 | $1.48 |
Total Assets | $1.43B | $1.35B | $1.31B | $1.27B |
Total Liabilities | $503.33M | $440.80M | $402.78M | $384.46M |
Cash & Equivalents | $196.26M | $193.22M | $187.84M | $186.74M |
Free Cash Flow OCF − CapEx | $12.28M | $58.05M | $32.82M | $-29.46M |
Shares Outstanding | 25.28M | 25.22M | 25.73M | 25.86M |